CGL
Clarius Group LLC’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Hold |
28,601
| – | – | 0.01% | 465 |
|
|
2025
Q1 | $151K | Hold |
28,601
| – | – | 0.01% | 468 |
|
|
2024
Q4 | $193K | Hold |
28,601
| – | – | 0.01% | 433 |
|
|
2024
Q3 | $188K | Hold |
28,601
| – | – | 0.01% | 435 |
|
|
2024
Q2 | $215K | Hold |
28,601
| – | – | 0.02% | 400 |
|
|
2024
Q1 | $285K | Hold |
28,601
| – | – | 0.02% | 346 |
|
|
2023
Q4 | $282K | Hold |
28,601
| – | – | 0.02% | 369 |
|
|
2023
Q3 | $219K | Hold |
28,601
| – | – | 0.02% | 419 |
|
|
2023
Q2 | $214K | Hold |
28,601
| – | – | 0.02% | 477 |
|
|
2023
Q1 | $191K | Hold |
28,601
| – | – | 0.02% | 484 |
|
|
2022
Q4 | $221K | Hold |
28,601
| – | – | 0.02% | 463 |
|
|
2022
Q3 | $304K | Hold |
28,601
| – | – | 0.03% | 341 |
|
|
2022
Q2 | $233K | Buy |
28,601
+15,001
| +110% | +$122K | 0.02% | 402 |
|
|
2022
Q1 | $233K | Hold |
13,600
| – | – | 0.02% | 436 |
|
|
2021
Q4 | $233K | Buy |
+13,600
| New | +$233K | 0.02% | 436 |
|